The effect of polymorphisms in tumor necrosis factor-α, interleukin-10, and transforming growth factor-β1 genes in acute hepatic allograft rejection

Transplantation

Volumn 69, Issue 7, 2000, Pages 1514-1517

  Bathgate, Andrew J ^a   Pravica, Vera ^b   Perrey, Chris ^b   Therapondos, George ^a   Plevris, John N ^a   Hayes, Peter C ^a   Hutchinson, Ian V ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0034655762     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004150-00054     Document Type: Article

References (23)

1. Fisher LR, Henley KS, Lucey MR. Acute cellular rejection after liver transplantation: variability, morbidity and mortality. Liver Transpl Surg 1995; 1: 10.
2. Imagawa DK, Milliss JM, Olthoff KM, et al. The role of tumour necrosis factor in allograft rejection. I. Evidence that elevated levels of tumour necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation 1990; 50: 189.
3. Martinez OM, Krams SM, Sternbeck M, et al. Intragraft cytokine profile during human liver allograft rejection. Transplantation 1992; 53: 449.
4. Gorczynski RM, Adams RB, Levy GA, Chung SW. Correlation of peripheral blood lymphocyte and intragraft cytokine mRNA expression with rejection in orthotopic liver transplantation. Surgery 1996; 120: 496.
5. Conti F, Boulland ML, Leroy-Viard K, et al. Low level of interleukin 10 synthesis during allograft rejection. Lab Invest 1998; 78: 1281.
6. Bishop GA, Rokahr KL, Napoli J, McCaughan GW. Intragraft cytokine mRNA levels in human liver allograft rejection analysed by reverse transcription and semiquantitative polymerase chain reaction amplification. Transpl Immunol 1993; 1: 253.
7. Platz KP, Mueller AR, Rossairt R, et al. Cytokine pattern during rejection and infection after liver transplantation: improvements in postoperative monitoring? Transplantation 1996; 62: 1441.
8. Louis E, Franchimont D, Piron A, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401.
9. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1.
10. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-betal production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998; 66: 1014.
11. Perrey C, Pravica V, Sinnott PJ, Hutchinson IV. Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report. Transpl Immunol 1998; 6: 193.
12. Doussett B, Conti F, Cherruau B, et al. Is acute rejection deleterious to long-term liver allograft function? J Hepatol 1998; 29: 660.
13. Wiesner RH, Demetris AJ, Belle SH, et al. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998; 28: 638.
14. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwjatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508.
15. Warzocha K, Ribeiro P, Bienvenu J, et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998; 91: 3574.
16. Turner DM, Grant-SC, Yonan N, et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997; 64: 776.
17. Sankaran D, Asderakis A, Ashraf S, et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999; 56: 281.
18. Freeman RB, Tran C-L, Mattoli J, et al. Tumor necrosis factor genetic polymorphisms correlate with infections after liver transplantation. Transplantation 1999; 67: 1005.
19. Tagore A, Gosalkorale WM, Whorwell PJ, Sinnott PJ, Hutchinson IV. Interleukin-10 genotype and susceptibility to inflammatory bowel disease. Gut 1998; 42: 49A.
20. Xu GP, Sharma VK, Li B, et al. Intragraft expression of IL-10 messenger RNA: a novel correlate of renal allograft rejection. Kidney Int 1995; 48: 1504.
21. Suthanthiran M, Strom TB. Mechanisms and management of acute renal allograft rejection. Surg Clin North Am 1998; 78: 77.
22. Lagoo AS, George JF, Naftel DC, et al. Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients. J Heart Lung Transplant 1996; 15: 156.
23. Densem CG, Hutchinson IV, Cooper A, Roberts T, Yonan N, Brooks NH. Low producers of TGF beta are protected from cardiac transplant vasculopathy. J Heart Lung Transpl 1999; 18: 52A.